(lp0
S"Horizon Fights Par Pharma's Generic Of Urine Disorder Drug Law360  - Jul 1, 2016 Horizon Therapeutics Inc. claims Par Pharmaceutical Inc. infringed its three Ravicti patents when it applied for an abbreviated new drug application with the Food and Drug Administration."
p1
aS"Horizon Therapeutics  Receives Media Impact Rating of 0.31 Markets Daily - Apr 8, 2017 Alpha One also gave news articles about Horizon Therapeutics an impact score of 100 out of 100, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near term. Shares of Horizon Therapeutics&nbsp;...Horizon Therapeutics Inc - Receive News &amp; Ratings Daily - BBNS"
p2
aS"Buzz Stocks: Sears Holdings Corp, Horizon Pharma PLC, and Voyager Therapeutics Inc Schaeffers Research  - Dec 8, 2016 Among specific equities in focus today are retail stock Sears Holdings Corp , as well as drugmakers Horizon Pharma PLC  and Voyager Therapeutics Inc . Here's a quick look at what's driving SHLD, HZNP,&nbsp;..."
p3
aS'New Drugs for Insys Therapeutics Inc  and Horizon Pharma PLC Lead ... Smarter Analyst - Jul 6, 2016 Healthcare companies Insys Therapeutics Inc  and Horizon Pharma PLC  both received bullish sentiments from analysts this past week.Insys Therapeutics  Stock Soars on FDA Approval - TheStreet.com'
p4
aS"PTAB Upholds Patent For Horizon's Urine Disorder Drug Law360  - Nov 4, 2016 Horizon picked up Ravicti and a second drug used to treat urea cycle disorders, Buphenyl, when it acquired California biotech company Hyperion Therapeutics Inc. for $1.1 billion last year. The disorders are caused by genetic mutations that prevent a&nbsp;..."
p5
aS"2 Stocks to keep an eye on Today: Juno Therapeutics, Inc. , First ... StockNewsJournal - Apr 5, 2017 Juno Therapeutics, Inc.  market capitalization at present is $2.41B at the rate of $23.05 a share. The firm's price-to-sales ratio was noted 29.71 in contrast with an overall industry average of 120.00."
p6
aS'Analyst Recommendations And Earnings Forecast: Horizon Global Corporation (HZN ... Post Analyst - Mar 17, 2017 Horizon Global Corporation  has made its way to a 12-month gain of 21.92%. Turning to INSYS Therapeutics, Inc. , its shares were trading at $10.06 a retreat of $-0.49, on the trading floor. The stock, after opening at $10.46, touched ...Richard D. Siebert Acquires 1000 Shares of Horizon Global Corp  Stock - Chaffey Breeze'
p7
aS'Somewhat Positive Press Coverage Somewhat Unlikely to Effect Horizon ... Chaffey Breeze - Apr 13, 2017 Horizon Therapeutics logo Press coverage about Horizon Therapeutics  has trended somewhat positive recently, according to Alpha One.'
p8
aS'Horizon Minerals Corp  Seedy Individuals Want Your Cash On This One Insider Financial - Feb 7, 2017 Following the extremely brief success of his last pump and dump, Blake Insomnia Therapeutics Inc , our favorite Chicago pump and dumper nick named Napoleon by those who work under him in his office, is now turning his attention to&nbsp;...'
p9
aS"World's First Marijuana ETF Launched MarketWatch - Apr 5, 2017 Horizons ETFs Management  Inc.  is pleased to announce the launch of the Horizons Medical Marijuana Life Sciences ETF . Units of the exchange traded fund  begin trading on the Toronto Stock Exchange &nbsp;...ETF Offers Direct Exposure To Medical Cannabis Industry - StockhouseEmerald Announces Inclusion in the Industry's First ETF - Canada NewsWire "
p10
a.